Acanthosis nigricans-muscle cramps-acral enlargement syndrome
Acanthosis nigricans-muscle cramps-acral enlargement syndrome | |
---|---|
Other names | Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement |
Dilantin | |
Prognosis | Good to Ok |
Frequency | very rare, only 2 cases known to medical literature |
Acanthosis nigricans-muscle cramps-acral enlargement syndrome, also known as Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome is an extremely rare genetic disorder which is characterized by the appearance of acanthosis nigricans, insulin resistance, muscle cramps of severe intensity, and acral hypertrophy/enlargement.[1][2][3] Only 2 cases have been reported in medical literature.
It was first discovered when Jeffrey Flier and his colleagues described two siblings of the opposite sex with the symptoms mentioned above. (plus: large, chunky hands), the sister had virilized polycystic ovaries.[4] After being treated with dilantin, the cramps' severity lowered and the brother's insulin resistance also lowered.[5][6] The inheritance pattern of this disorder is thought to be autosomal recessive.[7]
References
- ^ "Acanthosis nigricans muscle cramps acral enlargement — About the Disease — Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Retrieved 2022-05-21.
- ^ RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Acanthosis nigricans insulin resistance muscle cramps acral enlargement syndrome". www.orpha.net.
{{cite web}}
: CS1 maint: numeric names: authors list (link) - ^ "Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome (Concept Id: C1860215) - MedGen — NCBI". www.ncbi.nlm.nih.gov. Retrieved 2022-05-21.
- PMID 6997748.
- ^ "OMIM Entry - 200170 - ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT". omim.org. Retrieved 2022-05-21.
- PMID 6997748.
- ^ "Acanthosis nigricans and insulin resistance with muscle cramp and acral enlargement syndrome (Concept Id: C4305258) - MedGen — NCBI". www.ncbi.nlm.nih.gov. Retrieved 2022-05-21.